https://preview.redd.it/cypfd9c65jeg1.png?width=1332&format=png&auto=webp&s=c2ff0a3c49d7870180ea1bb41fd7c45a89c34003
[https://www.bnl.gov/newsroom/news.php?a=212980](https://www.bnl.gov/newsroom/news.php?a=212980)
Fortunately, scientists have figured out how to harness actinium-225's power for good. They can attach it to molecules that can home in on only cancer cells. In clinical trials treating late-stage prostate cancer patients, actinium-225 wiped out the cancer in three treatments.
"There is no residual impact of the prostate cancer. It's remarkable,” said Kevin John, a researcher at the Department of Energy's (DOE) Los Alamos National Laboratory (LANL). Actinium-225 and treatments derived from it have also been used in [early trials](https://www.ncbi.nlm.nih.gov/pubmed/29423595) for leukemia, melanoma, and glioma.
But something stood in the way of expanding this treatment.
For decades, one place in the world has produced the majority of actinium-225: DOE's Oak Ridge National Laboratory (ORNL). Even with two other international facilities contributing smaller amounts, all three combined can only create enough actinium-225 to treat fewer than 100 patients annually. That's not enough to run anything but the most preliminary of clinical trials
[https://www.bwxt.com/bwxt-medical-submits-drug-master-file-for-actinium-225-api-to-u-s-food-and-drug-administration/](https://www.bwxt.com/bwxt-medical-submits-drug-master-file-for-actinium-225-api-to-u-s-food-and-drug-administration/)
1) Why don't US government speed up the approval for such drugs when the filing took place in June 2024?
[https://www.bwxtmedical.com/bwxt-medical-and-northstar-medical-radioisotopes-sign-supply-agreement-supporting-actinium-225-production/](https://www.bwxtmedical.com/bwxt-medical-and-northstar-medical-radioisotopes-sign-supply-agreement-supporting-actinium-225-production/)
BWXT Medical Ltd., a subsidiary of BWX Technologies, Inc. (NYSE: BWXT) and NorthStar Medical Radioisotopes, LLC (NorthStar) today announced that they have signed a Master Services Agreement (MSA), which will facilitate the production of actinium-225 (Ac-225), a critical medical isotope used to kill cancer cells while minimizing the impact to healthy tissues.
2) Strategic US govt equity investment into BWXT, which can then be used to greatly speed up the production of Ac-225. If targeting 1kg of Ac-225 is even remotely attainable that can greatly pay down the US govt debt.